5(6)-carboxyfluorescein |
Sodium glycocholate (SGC) and sodium taurodeoxycholate (STDC) |
In vitro: Caco-2 cell |
SGC was a slightly better absorption enhancer for the 5(6)-carboxyfluorescein than STDC but not significant (p > 0.05). |
[73] |
Cefquinome |
Sodium taurocholate |
In vitro: Caco-2 cell |
At 2 mmol/L sodium taurocholate, the transportation of cefquinome substantially increased. |
[72] |
In vivo: rat intestine |
At 10 and 20 mmol/L sodium taurocholate, the absorption of the drug increased in a concentration-dependent manner. |
Berberine chloride |
Sodium deoxycholate |
In vivo: rat intestine |
AUC0–36h: 35.3-fold increase |
[70] |
Gliclazide |
Taurocholic acid |
In vivo: rat intestine |
The microcapsules containing taurocholic acid increased the gliclazide absorption (p < 0.01). |
[71] |
EGFR2R-lytic hybrid peptide |
Sodium taurodeoxycholate |
In vitro: Caco-2 cell |
Papp: 5.0-fold increase |
[74] |